Matthew Erway

Statistics

Publications

Citations

243

H-Index

Active since

1998

Affiliations

Bristol-Myers Squibb (United States)(Current)

Matthew Erway is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, structure-activity relationships, and potassium channel pharmacology.

Publications per year

1998–2002

Publications

Synthesis and Structure−Activity Relationships of 3-Aryloxindoles: A New Class of Calcium-Dependent, Large Conductance Potassium (Maxi-K) Channel Openers with Neuroprotective Properties

Piyasena Hewawasam, Matthew Erway, Sandra L. Moon et al. · Journal of Medicinal Chemistry · 2002 · 186 citations

Medicine, Medicinal Chemistry, Pharmacology +17

The synthesis and structure–activity relationships of 1,3-diaryl 1,2,4-(4H)-triazol-5-ones: A new class of calcium-dependent, large conductance, potassium (maxi-k) channel opener targeted for urge urinary incontinence

Piyasena Hewawasam, Matthew Erway, George Thalody et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 36 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Reactivity and regioselectivity of magnesium phenolates towards isatins: One-step synthesis of 3-(2-hydroxyaryl)-3-hydroxyindolones

Piyasena Hewawasam, Matthew Erway · Tetrahedron Letters · 1998 · 21 citations

Pharmacy, Chemistry, Medicinal Chemistry +3

1–3 of 3